BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 17519421)

  • 1. Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study.
    Pearson ER; Donnelly LA; Kimber C; Whitley A; Doney AS; McCarthy MI; Hattersley AT; Morris AD; Palmer CN
    Diabetes; 2007 Aug; 56(8):2178-82. PubMed ID: 17519421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association study of the genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) gene and type 2 diabetes in the Chinese population.
    Chang YC; Chang TJ; Jiang YD; Kuo SS; Lee KC; Chiu KC; Chuang LM
    Diabetes; 2007 Oct; 56(10):2631-7. PubMed ID: 17579206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of TCF7L2 polymorphism with diabetes mellitus, metabolic syndrome, and markers of beta cell function and insulin resistance in a population-based sample of Emirati subjects.
    Saadi H; Nagelkerke N; Carruthers SG; Benedict S; Abdulkhalek S; Reed R; Lukic M; Nicholls MG
    Diabetes Res Clin Pract; 2008 Jun; 80(3):392-8. PubMed ID: 18282631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-grain consumption and transcription factor-7-like 2 ( TCF7L2) rs7903146: gene-diet interaction in modulating type 2 diabetes risk.
    Fisher E; Boeing H; Fritsche A; Doering F; Joost HG; Schulze MB
    Br J Nutr; 2009 Feb; 101(4):478-81. PubMed ID: 19149908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A variant of the transcription factor 7-like 2 (TCF7L2) gene and the risk of posttransplantation diabetes mellitus in renal allograft recipients.
    Kang ES; Kim MS; Kim YS; Hur KY; Han SJ; Nam CM; Ahn CW; Cha BS; Kim SI; Lee HC
    Diabetes Care; 2008 Jan; 31(1):63-8. PubMed ID: 17934151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss-of-function CYP2C9 variants improve therapeutic response to sulfonylureas in type 2 diabetes: a Go-DARTS study.
    Zhou K; Donnelly L; Burch L; Tavendale R; Doney AS; Leese G; Hattersley AT; McCarthy MI; Morris AD; Lang CC; Palmer CN; Pearson ER
    Clin Pharmacol Ther; 2010 Jan; 87(1):52-6. PubMed ID: 19794412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loci of TCF7L2, HHEX and IDE on chromosome 10q and the susceptibility of their genetic polymorphisms to type 2 diabetes.
    Nordman S; Ostenson CG; Efendic S; Gu HF
    Exp Clin Endocrinol Diabetes; 2009 Apr; 117(4):186-90. PubMed ID: 19053027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes.
    Cauchi S; Meyre D; Dina C; Choquet H; Samson C; Gallina S; Balkau B; Charpentier G; Pattou F; Stetsyuk V; Scharfmann R; Staels B; Frühbeck G; Froguel P
    Diabetes; 2006 Oct; 55(10):2903-8. PubMed ID: 17003360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variants of the transcription factor 7-like 2 gene (TCF7L2) are strongly associated with type 2 diabetes but not with the metabolic syndrome in the MONICA/KORA surveys.
    Marzi C; Huth C; Kolz M; Grallert H; Meisinger C; Wichmann HE; Rathmann W; Herder C; Illig T
    Horm Metab Res; 2007 Jan; 39(1):46-52. PubMed ID: 17226113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of genetic risk in three candidate genes (TCF7L2, PPARG, KCNJ11) with traditional risk factors for type 2 diabetes in a population-based study--the HUNT study.
    Thorsby PM; Midthjell K; Gjerlaugsen N; Holmen J; Hanssen KF; Birkeland KI; Berg JP
    Scand J Clin Lab Invest; 2009; 69(2):282-7. PubMed ID: 18972257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variations in TCF7L2 influence therapeutic response to sulfonylureas in Indian diabetics.
    Dhawan D; Padh H
    Diabetes Res Clin Pract; 2016 Nov; 121():35-40. PubMed ID: 27639123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of TCF7L2 polymorphisms with type 2 diabetes in Mexico City.
    Parra EJ; Cameron E; Simmonds L; Valladares A; McKeigue P; Shriver M; Wacher N; Kumate J; Kittles R; Cruz M
    Clin Genet; 2007 Apr; 71(4):359-66. PubMed ID: 17470138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KCNJ11 gene E23K variant and therapeutic response to sulfonylureas.
    Javorsky M; Klimcakova L; Schroner Z; Zidzik J; Babjakova E; Fabianova M; Kozarova M; Tkacova R; Salagovic J; Tkac I
    Eur J Intern Med; 2012 Apr; 23(3):245-9. PubMed ID: 22385882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TCF7L2 variation predicts hyperglycemia incidence in a French general population: the data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study.
    Cauchi S; Meyre D; Choquet H; Dina C; Born C; Marre M; Balkau B; Froguel P;
    Diabetes; 2006 Nov; 55(11):3189-92. PubMed ID: 17065361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haplotypes of transcription factor 7-like 2 (TCF7L2) gene and its upstream region are associated with type 2 diabetes and age of onset in Mexican Americans.
    Lehman DM; Hunt KJ; Leach RJ; Hamlington J; Arya R; Abboud HE; Duggirala R; Blangero J; Göring HH; Stern MP
    Diabetes; 2007 Feb; 56(2):389-93. PubMed ID: 17259383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCF7L2 in the Go-DARTS study: evidence for a gene dose effect on both diabetes susceptibility and control of glucose levels.
    Kimber CH; Doney AS; Pearson ER; McCarthy MI; Hattersley AT; Leese GP; Morris AD; Palmer CN
    Diabetologia; 2007 Jun; 50(6):1186-91. PubMed ID: 17429603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals.
    Saxena R; Gianniny L; Burtt NP; Lyssenko V; Giuducci C; Sjögren M; Florez JC; Almgren P; Isomaa B; Orho-Melander M; Lindblad U; Daly MJ; Tuomi T; Hirschhorn JN; Ardlie KG; Groop LC; Altshuler D
    Diabetes; 2006 Oct; 55(10):2890-5. PubMed ID: 17003358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The new type 2 diabetes gene TCF7L2.
    Florez JC
    Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):391-6. PubMed ID: 17563454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A paucimorphic variant in the HMG-CoA reductase gene is associated with lipid-lowering response to statin treatment in diabetes: a GoDARTS study.
    Donnelly LA; Doney AS; Dannfald J; Whitley AL; Lang CC; Morris AD; Donnan PT; Palmer CN
    Pharmacogenet Genomics; 2008 Dec; 18(12):1021-6. PubMed ID: 18815589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variants in TCF7L2 and KCNJ11 genes in a Greek population with polycystic ovary syndrome.
    Christopoulos P; Mastorakos G; Gazouli M; Panidis D; Deligeoroglou E; Katsikis I; Papadias K; Diamandi-Kandarakis E; Creatsas G
    Gynecol Endocrinol; 2008 Sep; 24(9):486-90. PubMed ID: 18958766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.